[biomarker data] LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
| Title | [biomarker data] LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer |
|---|---|
| Description | JZJC_RET prescreening test biomarker data from Amoy and EDC |
| Organism | Homo sapiens |
| Data Type | Genetic Biomarkers |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA023487 |
| Release Date | 2024-02-21 |
| Submitter | ling zhang (shfkgcp@163.com) |
| Organization | shanghai pulmonary hospital |
| Submission Date | 2024-02-06 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX005816-01 | JZJC_RET prescreening test biomarker data from Amoy and EDC | 3 | Genetic Biomarkers | 423.3 KB | zip | 0 | Unavailable |